Harold Bernstein sold $446K of Maze Therapeutics, Inc. (MAZE) stock

Harold Bernstein, President, R&D & CMO of Maze Therapeutics, Inc. (MAZE), sold 16,142 shares of MAZE stock worth $446K, per an SEC Form 4 filed Aug 14, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 13, 2026, 1 day before it was made public.

MAZE has moved +2.6% since the trade date, from $27.66 to $28.38 (Sep 22, 2026 close).